At a glance
ClinicalIndex Comparison RecordN/ACompleted· 236 enrolled
Drug / intervention
Ramelteondrug
Likely dose
Ramelteon 8 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Rozerem 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Associated With Sleep-onset Difficulty > - Transitional Survey From the Preceding Drug-use Survey -
In Brief
An observational study evaluating Ramelteon for Insomnia. Completed, enrolled 236 participants across 2 sites.
Detailed Summary
The purpose of this survey is to examine the safety and efficacy of long-term use of ramelteon tablets (Rozerem 8 mg Tablets) in participants with difficulty falling asleep associated with insomnia in daily medical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInsomnia
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2011
Primary CompletionJun 2014
First PostedJun 2014
TodayJul 2026
First PostedJun 2, 2014
Enrollment StartMar 1, 2011
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 12.1 years ago
Interventions
Ramelteondrug
Ramelteon tablets 8 mg